Skip to main content
. 2017 Aug 9;8(45):79864–79875. doi: 10.18632/oncotarget.20094

Table 3. Adverse events in subjects treated with fludarabine and methoxyamine.

Toxicity All Grades (%) Grade 3 – 4 (%)
Hematologic N % N %
 Leukopenia 17 85 10 50
 Neutropenia 15 75 12 60
 Anemia 20 100 8 40
 Thrombocytopenia 13 65 5 25
 Lymphopenia 16 80 14 70
Gastrointestinal
 Anorexia 10 50 0 0
 Constipation 9 45 0 0
 Diarrhea 5 25 1 5
 Nausea 13 65 0 0
 Vomiting 5 25 0 0
Neurologic
 Insomnia 7 35 1 5
 Dizziness 2 10 0 0
 Paresthesias 10 50 0 0
 Pain 8 40 1 5
Respiratory
 Cough 2 10 0 0
 Dyspnea 7 35 0 0
General
 Fatigue 17 85 0 0
Cutaneous/Dermatologic
 Alopecia 3 15 0 0
 Erythema 2 10 0 0
 Pruritus 2 10 0 0
Infectious
 Fever 6 30 1 5
 Infection 5 25 3 15
Cardiovascular
 Edema 3 15 0 0
Laboratory
 Hyperbilirubinemia 8 40 0 0
 Hypokalemia 3 15 0 0
 Hyperuricemia without TLS 3 15 1 5
 Hypoalbuminemia 7 35 1 5
 Hyponatremia 8 40 0 0
 Hypocalcemia 11 55 0 0
 Transaminase elevation 5 25 1 5
 Creatinine elevation 5 25 0 0
 Haptoglobin decrease 6 30 0 0